Uniseed has entered a co-investment pact with BioCurate, a drug discovery fund for early-stage University of Melbourne and Monash University research.
BioCurate, a state government-backed medical research engine formed by University of Melbourne and Monash University, joined forces with multi-university venturing fund Uniseed in a commercialisation and development partnership yesterday.
The agreement will form the basis for co-investment opportunities between BioCurate and Uniseed targeting drug research and therapeutics.
Founded in 2016 with A$25m ($17.1m) each from University of Melbourne and Monash University, BioCurate is intended to facilitate the development of new medicines by investing in early-stage research from both…
